Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

NCT03799627 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Dialysis-dependent Chronic Kidney Disease

Interventions

DRUG: Vadadustat
DRUG: Epoetin Alfa
DRUG: Vadadustat TIW

Sponsor

Akebia Therapeutics